Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
J Kenicer(Edinburgh Cancer Research), John M.S. Bartlett(Edinburgh Cancer Research), Nicola Lyttle(Ontario Institute for Cancer Research), Alan Mackay(Institute of Cancer Research), Karen J. Taylor(Edinburgh Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Cindy Q. Yao(Ontario Institute for Cancer Research), Maryou B. Lambros(Institute of Cancer Research), Melanie Spears(Ontario Institute for Cancer Research), Carrie Cunningham(Edinburgh Cancer Research), Linda M. Liao(National Institutes of Health)
Cited by 27
Related Papers
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k